| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-06 |